Recomendaciones de manejo de la afectación renal en el complejo esclerosis tuberosa

Mostra el registre complet Registre parcial de l'ítem

• dc.contributor.author Ariceta, Gema
• dc.contributor.author Buj, María José
• dc.contributor.author Furlano, Mónica
• dc.contributor.author Martínez, Víctor
• dc.contributor.author Matamala, Anna
• dc.contributor.author Morales, Montserrat
• dc.contributor.author Robles, Nicolás Roberto
• dc.contributor.author Sans Atxer, Laia
• dc.contributor.author Villacampa, Felipe
• dc.contributor.author Torra, Roser
• dc.date.accessioned 2021-03-10T08:00:52Z
• dc.date.available 2021-03-10T08:00:52Z
• dc.date.issued 2020
• dc.description.abstract Tuberous sclerosis complex (TSC) is a rare, hereditary, multisystemic disease with a broad phenotypic spectrum. Its management requires the collaboration of multiple specialists. Just as in the paediatric age, the paediatric neurologist takes on special importance; in adulthood, renal involvement is the cause of the greatest morbidity and mortality. There are several recommendations on the general management of patients with TSC but none that focuses on renal involvement. These recommendations respond to the need to provide guidelines to facilitate a better knowledge and diagnostic-therapeutic management of the renal involvement of TSC through a rational use of complementary tests and the correct use of available treatments. Their elaboration has been based on consensus within the hereditary renal diseases working group of the SEN/REDINREN (Spanish Society of Nephrology/Kidney Research Network). It has also counted on the participation of non-nephrologist specialists in TSC in order to expand the vision of the disease.
• dc.format.mimetype application/pdf
• dc.identifier.citation Ariceta G, Buj MJ, Furlano M, Martínez V, Matamala A, Morales M, et al. Recomendaciones de manejo de la afectación renal en el complejo esclerosis tuberosa. Nefrologia. 2020 Mar-Apr; 40(2):142-51. DOI: 10.1016/j.nefro.2019.07.002
• dc.identifier.doi http://dx.doi.org/10.1016/j.nefro.2019.07.002
• dc.identifier.issn 0211-6995
• dc.identifier.uri http://hdl.handle.net/10230/46712
• dc.language.iso spa
• dc.publisher Elsevier
• dc.rights 0211-6995/© 2019 Publicado por Elsevier España, S.L.U. en nombre de Sociedad Española de Nefrología. Este es un articulo Open Access bajo la licencia CC BY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/).
• dc.rights.accessRights info:eu-repo/semantics/openAccess
• dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/4.0/
• dc.subject.keyword Angiomiolipomas
• dc.subject.keyword Angiomyolipomas
• dc.subject.keyword Contiguous gene syndrome
• dc.subject.keyword Cysts
• dc.subject.keyword Enfermedad renal poliquística
• dc.subject.keyword Esclerosis tuberosa
• dc.subject.keyword Polycystic kidney disease
• dc.subject.keyword Proteína mTOR
• dc.subject.keyword Quistes
• dc.subject.keyword Síndrome del gen contiguo
• dc.subject.keyword Tuberous sclerosis
• dc.subject.keyword mTOR protein
• dc.subject.keyword
• dc.title Recomendaciones de manejo de la afectación renal en el complejo esclerosis tuberosa
• dc.title.alternative Recommendations for the management of renal involvement in the tuberous sclerosis complex
• dc.type info:eu-repo/semantics/article
• dc.type.version info:eu-repo/semantics/publishedVersion